Join ICON at World Vaccine Congress 2026 as we share our latest insights in HIV vaccine and therapeutic development. With 30+ HIV studies, 13,800+ participants, and 20+ years of operational experience across 27 African a...
ICON portfolio of AI tools drives clinical trial efficiencies
Enterprise Ireland grant awarded to ICON to further enhance artificial intelligence capabilities
Read the press releaseBiomarker and trial optimisation needed to drive R&D progress in Alzheimer’s and related disorders
ICON survey
Read the press release